168 related articles for article (PubMed ID: 17080010)
21. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of HER2-induced endothelial cell retraction.
Carter WB; Niu G; Ward MD; Small G; Hahn JE; Muffly BJ
Ann Surg Oncol; 2007 Oct; 14(10):2971-8. PubMed ID: 17593333
[TBL] [Abstract][Full Text] [Related]
23. Cadherin superfamily of adhesion molecules in primary lung cancer.
Charalabopoulos K; Gogali A; Kostoula OK; Constantopoulos SH
Exp Oncol; 2004 Dec; 26(4):256-60. PubMed ID: 15627055
[TBL] [Abstract][Full Text] [Related]
24. Markers of melanocytic tumour progression.
Ruiter DJ; van Muijen GN
J Pathol; 1998 Dec; 186(4):340-2. PubMed ID: 10209480
[TBL] [Abstract][Full Text] [Related]
25. Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance.
Orecchia S; Schillaci F; Salvio M; Libener R; Betta PG
Lung Cancer; 2004 Aug; 45 Suppl 1():S37-43. PubMed ID: 15261432
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
27. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
28. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
Fujii K; Furukawa F; Matsuyoshi N
Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M
Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826
[TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
[TBL] [Abstract][Full Text] [Related]
32. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
[TBL] [Abstract][Full Text] [Related]
33. Roles of E- and P-cadherin in the human skin.
Furukawa F; Fujii K; Horiguchi Y; Matsuyoshi N; Fujita M; Toda K; Imamura S; Wakita H; Shirahama S; Takigawa M
Microsc Res Tech; 1997 Aug; 38(4):343-52. PubMed ID: 9297684
[TBL] [Abstract][Full Text] [Related]
34. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
35. A secreted form of P-cadherin is expressed in malignant melanoma.
Bauer R; Hein R; Bosserhoff AK
Exp Cell Res; 2005 May; 305(2):418-26. PubMed ID: 15817166
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
Yuan Z; Wong S; Borrelli A; Chung MA
Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
[TBL] [Abstract][Full Text] [Related]
37. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
38. Cadherins and catenins in breast cancer.
Cowin P; Rowlands TM; Hatsell SJ
Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
[TBL] [Abstract][Full Text] [Related]
39. Variation in cadherins and catenins expression is linked to both proliferation and transformation of Rhabdomyosarcoma.
Charrasse S; Comunale F; Gilbert E; Delattre O; Gauthier-Rouvière C
Oncogene; 2004 Mar; 23(13):2420-30. PubMed ID: 14691446
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin cell-cell communication in melanogenesis and during development of malignant melanoma.
Kuphal S; Bosserhoff AK
Arch Biochem Biophys; 2012 Aug; 524(1):43-7. PubMed ID: 22085498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]